Table Of Contents

1. Market Context & Strategic Relevance

 1.1 Opening Context (Why the market matters)

 1.1.1 Why This Market Is Gaining Strategic Attention

     1.1.2 Business Decisions This Report Supports

 1.2 Scope

     1.3 Research & Methodology

2. Executive Summary

 2.1 Market Snapshot

 2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2022–2035

 2.3 Market Size & Forecast, By Segmentation, 2022–2035

  2.3.1 Market Size By Business Model

  2.3.2 Market Size By Services

  2.3.3 Market Size By End-User

 2.3.4 Market Size By Health Plan

 2.4 Market Share & Bps Analysis By Region, 2025

 2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic

 2.6 Industry CxO’s Perspective

3. Market Overview

 3.1 Market Dynamics

  3.1.1 Drivers

  3.1.2 Restraints

  3.1.3 Opportunities

  3.1.4 Key Market Trends

 3.2 Industry PESTLE Analysis

 3.3 Key Industry Forces (Porter’s) Impacting Market Growth

 3.4 Industry Supply Chain Analysis

  3.4.1 Pharmaceutical Manufacturers & Drug Suppliers

3.4.2. PBM Services & Benefit Management

3.4.3. Pharmacy Networks & Healthcare Providers

3.4.4. Payers, Health Plans & End Users

 3.5 Industry Life Cycle Assessment

4. Statistical Insights & Trends Reporting

 4.1 Prescription & Drug Utilization Trends

  4.1.1. Prescription Volume and Utilization Trends

  4.1.2. Generic vs. Brand Drug Utilization Trends

  4.1.3. Specialty Drug Utilization Trends

  4.1.4. GLP-1 Prescription and Utilization Trends

4.2. Pharmacy Benefit & Rebate Trends

  4.2.1. Rebate and Discount Trends

  4.2.2. Formulary Management Trends

  4.2.3. Drug Spend and Cost-Sharing Trends

  4.2.4. Specialty Drug Spending Trends

4.3. PBM Operational & Service Trends

  4.3.1. Mail-Order Pharmacy Utilization Trends

  4.3.2. Specialty Pharmacy Service Adoption

  4.3.3. Prior Authorization and Utilization Management Trends

  4.3.4. Digital Pharmacy and Member Engagement Trends

4.4. Regulatory & Technology Trends

  4.4.1. PBM Pricing Transparency Trends

  4.4.2. AI and Data Analytics Adoption in PBM Operations

  4.4.3. Value-Based Pharmacy Benefit Management Trends

  4.4.4. Regulatory and Policy Developments Impacting PBMs

5. U.S. Pharmacy Benefit Management (PBM) Market Segmental Analysis & Forecast, By Business Model, 2022–2035, Value (USD Billion)

5.1 Introduction

 5.2 Standalone PBM

  5.2.1 Key Trends

  5.2.2 Market Size & Forecast, 2022–2035

 5.3 Healthcare Insurance Provider

 5.4 Insurance Companies & Retail Pharmacies

6. U.S. Pharmacy Benefit Management (PBM) Market Segmental Analysis & Forecast, By Services, 2022–2035, Value (USD Billion)

    6.1 Introduction

 6.2 Specialty Pharmacy Services

  6.2.1 Key Trends

  6.2.2 Market Size & Forecast, 2022–2035

 6.3 Retail Pharmacy Networks

 6.4 Mail-Order Pharmacy Services

 6.5 Claims Processing

7. U.S. Pharmacy Benefit Management (PBM) Market Segmental Analysis & Forecast, By End-User, 2022–2035, Value (USD Billion)

    7.1 Introduction

 7.2 Federal/Government Programs

  7.2.1 Key Trends

  7.2.2 Market Size & Forecast, 2022–2035

 7.3 Commercial

 7.4 Medicaid

8. U.S. Pharmacy Benefit Management (PBM) Market Segmental Analysis & Forecast, By Health Plan, 2022–2035, Value (USD Billion)

    8.1 Introduction

 8.2 Commercial Health Plans

  8.2.1 Key Trends

  8.2.2 Market Size & Forecast, 2022–2035

 8.3 Medicare Plans

 8.4 Medicaid Plans

9. U.S. Pharmacy Benefit Management (PBM) Market Segmental Analysis & Forecast By Region, 2022–2035, Value (USD Billion)

9.1 Introduction

9.2 North America

 9.2.1 Key Trends

 9.2.2 U.S. Pharmacy Benefit Management (PBM) Market Size & Forecast, By Business Model, 2022–2035

 9.2.3 U.S. Pharmacy Benefit Management (PBM) Market Size & Forecast, By Services, 2022–2035

 9.2.4 U.S. Pharmacy Benefit Management (PBM) Market Size & Forecast, By End-User, 2022–2035

 9.2.5 U.S. Pharmacy Benefit Management (PBM) Market Size & Forecast, By Health Plan, 2022–2035

 9.2.6 U.S. Pharmacy Benefit Management (PBM) Market Size & Forecast, By Country, 2022–2035

  9.2.6.1 USA

  9.2.6.2 Canada

9.3 Europe

 9.3.1 Key Trends

 9.3.2 U.S. Pharmacy Benefit Management (PBM) Market Size & Forecast, By Business Model, 2022–2035

 9.3.3 U.S. Pharmacy Benefit Management (PBM) Market Size & Forecast, By Services, 2022–2035

 9.3.4 U.S. Pharmacy Benefit Management (PBM) Market Size & Forecast, By End-User, 2022–2035

 9.3.5 U.S. Pharmacy Benefit Management (PBM) Market Size & Forecast, By Health Plan, 2022–2035

 9.3.6 U.S. Pharmacy Benefit Management (PBM) Market Size & Forecast, By Country, 2022–2035

  9.3.6.1 Germany

  9.3.6.2 UK

  9.3.6.3 France

  9.3.6.4 Italy

  9.3.6.5 Spain

  9.3.6.6 Russia

  9.3.6.7 Poland

  9.3.6.8 Rest of Europe

9.4 Asia-Pacific

 9.4.1 Key Trends

 9.4.2 U.S. Pharmacy Benefit Management (PBM) Market Size & Forecast, By Business Model, 2022–2035

 9.4.3 U.S. Pharmacy Benefit Management (PBM) Market Size & Forecast, By Services, 2022–2035

 9.4.4 U.S. Pharmacy Benefit Management (PBM) Market Size & Forecast, By End-User, 2022–2035

 9.4.5 U.S. Pharmacy Benefit Management (PBM) Market Size & Forecast, By Health Plan, 2022–2035

 9.4.6 U.S. Pharmacy Benefit Management (PBM) Market Size & Forecast, By Country, 2022–2035

  9.4.6.1 China

  9.4.6.2 India

  9.4.6.3 Japan

  9.4.6.4 South Korea

  9.4.6.5 Australia

  9.4.6.6 ASEAN Countries

  9.4.6.7 Rest of Asia-Pacific

9.5 Latin America

 9.5.1 Key Trends

 9.5.2 U.S. Pharmacy Benefit Management (PBM) Market Size & Forecast, By Business Model, 2022–2035

 9.5.3 U.S. Pharmacy Benefit Management (PBM) Market Size & Forecast, By Services, 2022–2035

 9.5.4 U.S. Pharmacy Benefit Management (PBM) Market Size & Forecast, By End-User, 2022–2035

 9.5.5 U.S. Pharmacy Benefit Management (PBM) Market Size & Forecast, By Health Plan, 2022–2035

 9.5.6 U.S. Pharmacy Benefit Management (PBM) Market Size & Forecast, By Country, 2022–2035

  9.5.6.1 Brazil

  9.5.6.2 Argentina

  9.5.6.3 Mexico

  9.5.6.4 Colombia

  9.5.6.5 Rest of Latin America

9.6 Middle East & Africa

 9.6.1 Key Trends

 9.6.2 U.S. Pharmacy Benefit Management (PBM) Market Size & Forecast, By Business Model, 2022–2035

 9.6.3 U.S. Pharmacy Benefit Management (PBM) Market Size & Forecast, By Services, 2022–2035

 9.6.4 U.S. Pharmacy Benefit Management (PBM) Market Size & Forecast, By End-User, 2022–2035

 9.6.5 U.S. Pharmacy Benefit Management (PBM) Market Size & Forecast, By Health Plan, 2022–2035

 9.6.6 U.S. Pharmacy Benefit Management (PBM) Market Size & Forecast, By Country, 2022–2035

  9.6.6.1 UAE

  9.6.6.2 Saudi Arabia

  9.6.6.3 Qatar

  9.6.6.4 South Africa

  9.6.6.5 Rest of Middle East & Africa

10. Competitive Landscape

 10.1 Key Players' Positioning

 10.2 Competitive Developments

  10.2.1 Year-Wise Strategies & Development, 2022–2026

 10.3 Market Share Analysis, 2025

 10.4 Business Model/Service & Services Benchmarking

  10.4.1 Business Model/Service Specifications & Features By Key Players

  10.4.2 Business Model/Service Heatmap By Key Players

  10.4.3 Services Heatmap By Key Players

 10.5 Industry Start-Up & Innovation Landscape

10.6 Key Company Profiles

 10.6.1 CVS Health Corporation (CVS Caremark)

  10.6.1.1 Company Overview & Snapshot

  10.6.1.2 Business Model/Service Portfolio

  10.6.1.3 Key Company Financials

         10.6.1.4 Geographical Presence

  10.6.1.5 SWOT Analysis

 10.6.2 The Cigna Group (Express Scripts/Evernorth Health Services)

10.6.3. UnitedHealth Group Incorporated (OptumRx)

10.6.4. Humana Inc. (Humana Pharmacy Solutions)

10.6.5. Prime Therapeutics LLC

10.6.6. MedImpact Healthcare Systems, Inc.

10.6.7. Elixir Rx Solutions, LLC

10.6.8. Navitus Health Solutions, LLC

10.6.9. EmpiRx Health LLC

10.6.10. Capital Rx, Inc.

10.6.11. Rightway Healthcare, Inc.

10.6.12. Abarca Health, LLC

10.6.13. SmithRx, Inc.

10.6.14. Elevance Health, Inc. (IngenioRx)

10.6.15. Centene Corporation

10.6.16. Molina Healthcare, Inc.

10.6.17. WellDyneRx, LLC

10.6.18. PerformRx, LLC

10.6.19. Envision Rx (ProAct, Inc.)

10.6.20. Change Healthcare Inc. (UnitedHealth Group)

11. Analyst Recommendations

 11.1 SNS Insider Opportunity Map

 11.2 Industry Low-Hanging Fruit Assessment

 11.3 Market Entry & Growth Strategy

 11.4 Analyst Viewpoint & Suggestions on Market Growth

12. Assumptions

13. Disclaimer

14. Appendix

 14.1 List Of Tables

 14.2 List Of Figures